PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Psychiatry Res. Author manuscript; available in PMC May 30, 2011.
Published in final edited form as:
PMCID: PMC2868959
NIHMSID: NIHMS144077
Traumatic experiences, major life stressors, and self-reporting a physician-given fibromyalgia diagnosis
Mark G. Haviland,a*1 Kelly R. Morton,b Keiji Oda,c and Gary E. Fraserd
aDepartment of Psychiatry, Loma Linda University School of Medicine, Loma Linda, CA, USA
bDepartments of Family Medicine and Psychology, Loma Linda University Schools of Medicine and Science and Technology, Loma Linda, CA, USA
cDepartment of Epidemiology and Biostatistics, Loma Linda University School of Public Health, Loma Linda, CA, USA
dDepartments of Epidemiology and Biostatistics and Internal Medicine, Loma Linda University Schools of Public Health and Medicine, Loma Linda, CA, USA
*Corresponding author. Department of Psychiatry, Loma Linda University School of Medicine, 11374 Mountain View Avenue, Loma Linda, CA, 92354-3842. Tel.: 909-558-4505; fax: 909-558-6093. mhaviland/at/llu.edu (M. Haviland)
1Present address: Department of Psychiatry, Loma Linda University School of Medicine, 11374 Mountain View Avenue, Loma Linda, CA, 92354-3842, USA
The contribution of stress to the pathophysiology of fibromyalgia has been the subject of considerable debate. The primary purpose of the present study was to evaluate the relationship between traumatic and major life stressors and a fibromyalgia diagnosis in a large group of older women and men. Data were from the federally-funded Biopsychosocial Religion and Health Study, and subjects were 10,424 of the 10,988 survey respondents—two-thirds women and one-third men—providing responses to a fibromyalgia question. Average age was 61.0 ± 13.5 years. A physician-given fibromyalgia diagnosis in a subject’s lifetime was reported by 3.7% of the sample, 4.8% of the women and 1.3% of the men. In two multivariable logistic regression models (all respondents and women only, controlling for age, sex, race/ethnicity, and education), two traumatic experience types (sexual and physical assault/abuse) were associated with a fibromyalgia diagnosis. Two other trauma types (life-threatening and emotional abuse/neglect) and major life stress experiences were not. The highest odds ratios in both models were those for sexual assault/abuse followed by physical assault/abuse. The relationship between age and fibromyalgia was curvilinear in both models (odds ratios rising until approximately age 63 and declining thereafter). In the all-subjects model, being a woman increased the odds of a fibromyalgia diagnosis, and in both models, fibromyalgia was associated with being White (versus non-White) and lower education. We recommend that researchers investigate the relationship between stress and fibromyalgia in concert with genetic and biomarker studies.
Keywords: Fibromyalgia, Trauma, Stress, Sexual abuse, Physical abuse
Fibromyalgia is a complex and difficult-to-treat medical condition characterized by widespread musculoskeletal pain, decreased pain threshold, and multiple “tender-points” in all four body quadrants (Clauw and Taylor-Moon, 2006; Chakrabarty and Zoorob, 2007; National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2007; Abeles et al., 2008; Wolfe and Rasker, 2008). Prominent associated symptoms/comorbidities include chronic fatigue, sleep disturbances, mood (depression and anxiety) disorders, and irritable bowel syndrome (Bradley, 2008; Schweinhardt et al., 2008; Wolfe and Rasker, 2008).
Fibromyalgia symptoms have been described for centuries and given various labels (e.g., muscular rheumatism and fibrositis) (Inanici and Yunus, 2004). The modern term, fibromyalgia, was coined in the mid-1970s, but it was not until the 1980s that its present formulation was established and, to some extent, legitimized (Yunus, et al., 1981; Goldenberg, 1987; Inanici and Yunus, 2004). In 1990, the American College of Rheumatology established research diagnostic criteria (pain and tender point evaluations), which now are used to diagnose the disorder (Wolfe et al., 1990). Although recognized as a legitimate clinical entity by, for example, the American College of Rheumatology, the American Medical Association, the National Institute of Arthritis, Musculoskeletal, and Skin Diseases, and the World Health Organization (Starlanyl and Copeland, 2001), fibromyalgia, however, is a disputed medical condition (Bohr, 1996; Wolfe and Rasker, 2008; Wolfe, 2009). Many believe, for example, that fibromyalgia is not a disease but rather a collection of symptoms (overlapping most other “medically unexplained” syndromes) that place people at the upper end of a “pain-distress” continuum (Wolfe and Rasker, 2008). Moreover, Wolfe and Rasker (2008) also note that establishing a fibromyalgia “cut-point” is quite arbitrary and that such a cut-point has been made only for political and financial, but not, scientific reasons.
Fibromyalgia prevalence figures in the United States are based on a single study conducted in the early 1990s in Wichita, Kansas (sample approximately 88% White; Wolfe et al., 1995). They estimated that fibromyalgia was affecting 2% (3.7 million people) of the United States population (18 years and older), 3.4% of women and 0.5% of men. In women, prevalence estimates increased dramatically with age (as high as 7.0% in women in the 60 to 79 year age range). Based on 2005 Census Bureau adjustments, Lawrence and colleagues (2008), estimated the number of Americans with fibromyalgia to be approximately 5 million. What causes fibromyalgia is not known, and other than pain testing for making a diagnosis and following clinical course, there are no other biomarkers for susceptibility, diagnosis, or clinical outcome (Dadabhoy et al., 2008). Several factors appear to contribute to fibromyalgia’s pathophysiology: genetics (familial predisposition), abnormal neuroendocrine and autonomic nervous system function (disordered central pain processing), and environmental triggers (mechanical/physical trauma and psychosocial stressors) (Bradley, 2008). The relationship between reporting a fibromyalgia diagnosis and environmental triggers—specifically trauma and major life stressors—is the subject of the present study.
Trauma and major life stress likely do not cause fibromyalgia per se; some propose that in genetically susceptible people, early life and prolonged trauma/stress in adulthood affects brain modulatory circuitry of both pain and emotions (Crofford, 2007; Bradley, 2008; Schweinhardt et al., 2008), which could account for fibromyalgia patients’ enhanced pain responses and co-occurring symptoms. A critical review of studies on the relationship between traumatic stress (childhood abuse) and various chronic pain conditions in adulthood, however, supports an association in some cross-sectional, but not prospective, studies (Raphael et al., 2004). Moreover, although individual studies on the relationship between emotional, physical, and sexual abuse and specifically a fibromyalgia diagnosis are intriguing (e.g., Boisset-Pioro et al., 1995; Walker et al., 1997; Van Houdenhove et al., 2001; Ciccone, et al., 2005), reviews across all studies are inconclusive (Romans and Cohen, 2008; Russell and Raphael, 2008). That some traumatic experiences are related to fibromyalgia in one study and not in another, however, is unsurprising, given that sampling and methods vary considerably from study to study. Clearly needed are large, community-based (versus small, clinical) studies, with (a) sufficient numbers of individuals with fibromyalgia (given its relatively low base rate in the population) and (b) assessment of many and varied trauma/stress experiences.
The primary purpose of the present study is to address this need and evaluate the relationship between traumatic and major life stressors and self-reporting a physician-given fibromyalgia diagnosis in a relatively large group of older women and men.
2.1. Data Source
Data were from the Biopsychosocial Religion and Health Study (BRHS; Lee et al., 2008), which randomly sampled participants from the Adventist Health Study (AHS-2) – a cohort study of approximately 96,000 Seventh-day Adventists investigating cancer, diet, and lifestyle (Butler et al., 2008). Seventh-day Adventists are evangelical Protestants who include healthy lifestyle beliefs in their religious doctrine; as such, 1% smoke, 7% consume alcohol, and only 47% eat meat. In Butler and colleagues (2008), AHS-2 recruitment methods and sampling strategy are described; briefly, local church pastors of the approximately 1,000 Black and 3,500 non-Black Adventist congregations in North America selected a local church member to coordinate AHS-2 recruitment materials for their congregation. Moreover, a nationwide recruitment campaign included articles in national and regional church magazines and programs on Adventist television networks encouraging study enrollment. Those who enrolled but did not return a questionnaire received up to three mailed reminders.
From the resulting 96,000 AHS-2 participants, the BRHS team randomly sampled 20,000 Adventists in the U.S. and sent them an invitation to participate with a 20-page religion and health questionnaire followed by up to three mailed reminders (Lee et al., 2008). Among the study’s aims were to compare Black and White respondents on several stress, religion, and health variables, and, thus, one recruitment goal was to enroll at least 3400 Blacks and 6600 Whites. Data collection occurred between September, 2006 and August, 2007, with a return of 10,988 usable questionnaires.
2.2. Subjects
Subjects were 10,424 of the 10,988 survey respondents who provided yes or no responses to the fibromyalgia question, 67.3% women and 32.6% men. Average age was 61.0 years (SD = 13.5). The majority of the participants were non-Hispanic White (60.2%) or Black (34.3%), and the others were Hispanic (2.9%), Asian (2.3%), or mixed race/ethnicity (0.4%). A substantial percentage (43.4%) had college or post-graduate degrees, and approximately half had household incomes of $51,000 or more.
2.3. Measures
2.31. Fibromyalgia
In the fibromyalgia subgroup were respondents answering ‘yes’ to a yes-no question, “Has a physician ever diagnosed you with fibromyalgia.” The non-fibromyalgia subgroup included those answering ‘no’ to that same question.
2.3.2. Fibromyalgia symptoms and comorbidities
We measured four fibromyalgia symptoms—pain, energy, sleep, and depression severity—and two comorbidities, lifetime diagnoses of depression and irritable bowel syndrome. ‘Pain interfering with life’ was assessed with a single bodily pain item from the SF-12 version 2 (“During the past 4 weeks, how much did pain interfere with your normal work, including both work outside the home and housework?”), rated on a five-point scale ranging from not at all to extremely (Ware et al., 2002). ‘Having a lot of energy’ was assessed with a vitality item from the SF-12 version 2 (“How much of the time during the past four weeks did you have a lot of energy?”), rated on a five-point scale ranging from all of the time to none of the time (Ware et al., 2002). ‘Poor sleep’ was represented by an item average for three sleep quality questions (trouble falling asleep, waking too early, and waking in the middle of the night) during the past four weeks, each rated on a four-point scale (1 = rarely or never, 4 = almost every day; Ohayon, 2002). For depression severity, we used the 11-item version of the Center for Epidemiological Studies-Depression Scale (CES-D) (each item rated on a three-point scale, ranging from 0 or rarely/none to 2 or much/most of the time) (Kohout et al., 1993). The comorbidities, depression and irritable bowel syndrome, each were coded yes-no, based on subjects’ answers to the questions, has a physician ever diagnosed you with depression or irritable bowel syndrome.
2.3.3. Trauma and major life stressors
Items were taken from a modified version of the Trauma Assessment in Adults instrument and Ryff and colleagues’ child abuse scales (Cusak et al., 2004; Ryff et al., 2004; McHugo et al., 2005). Respondents were asked about various types of “stressful or difficult” life events, which we broadly classified as either a traumatic experience or a major life stressor. The trauma items represent experiences that likely involved actual or threatened death (actual death of another person) or serious injury (or threat to one’s physical integrity) and were accompanied by intense reactions (e.g., fear, helplessness, and horror) (Lazarus and Folkman, 1984; Shalev, 1996; American Psychiatric Association, 2000). We further classified traumatic experiences by type: (a) life-threatening (four questions: war, bad accident, natural disaster, witnessing someone seriously injured or killed), (b) emotional abuse/neglect (two questions about mother or father insulting, swearing at, or ignoring), (c) physical assault/abuse (two assault questions, actual and threatened in one’s lifetime; four abuse questions, mother or father pushing, slapping, throwing objects, kicking, biting, striking with an object), and (d) sexual assault/abuse (three questions, actual and threatened in one’s lifetime).
The major life stressors are serious illness (e.g., cancer, leukemia, AIDS, and multiple sclerosis), abortion (self/intimate partner), miscarriage (self/intimate partner), divorce/separation, homelessness, and death of a child. For each of these trauma/stressor variables, subjects were given a score of 0 in the category if their answers to all of the questions in that category were no/never (and given a score of 1, if otherwise).
2.4. Data Analyses
Bivariate
To compare respondents in the fibromyalgia and no fibromyalgia subgroups on biographic/demographic factors and fibromyalgia symptoms and comorbidities, we used t-tests for independent samples and chi square tests. For all tests of statistical significance, we set alpha at 0.05.
Multivariable logistic regression
Our dependent variable was reporting a fibromyalgia diagnosis (yes-no), and our main independent variables were trauma (life-threatening, emotional abuse/neglect, physical assault/abuse, and sexual assault/abuse) and major life stressors. Control variables were age, race/ethnicity, education, and income (categories are shown in Table 1). To evaluate model fit, we used the Hosmer and Lemshow goodness-of-fit test. A p-value > 0.05 suggests that model prediction does not significantly differ from the observed. Our preferred models are those with available data, which we present. We ran the models a second time with imputed data (multiple imputation, conditional on variables in the models) as well, and similarities and differences between the imputed and available data models are noted.
Table 1
Table 1
Age, Race/Ethnicity, Education, and Income by Fibromyalgia Diagnosis
Multivariate risk differences
To calculate multivariate risk differences, predicted probabilities of a fibromyalgia diagnosis were calculated for those with and without each of the trauma variables, holding other covariates constant at their mean value (education was set at some college or less) in multivariate logistic regression models. Standard errors for differences of predicted probabilities were computed using the delta method.
3.1. Fibromyalgia diagnosis
A physician-given fibromyalgia diagnosis (in one’s lifetime) was reported by 3.7% of the sample, 4.8% of the women and 1.3% of the men. The percentages for White subjects only (more comparable to the established figures) are 4.5% overall, 6.2% women, and 1.5% men; and for non-Whites, respectively, 2.3%, 2.7%, and 0.8%.
3.2. Bivariate comparisons
Biographic/demographic factors by fibromyalgia diagnosis for women, men, and all respondents are shown in Table 1. (In Table 1Table 3, due to rounding, not all percentages add up to 100.0, and the Total columns include subjects with missing gender data). The relationship between age and fibromyalgia diagnosis was not linear (details given below). Among all subjects, fibromyalgia was more common among Whites (based on a chi square test of Whites versus Black, Hispanic, Asian, and mixed race respondents combined). It also was more common among respondents with some college or less and among those with lower incomes; and less common among respondents with college and postgraduate degrees.
Table 3
Table 3
Trauma/Major Life Stressors by Fibromyalgia Diagnosis
Fibromyalgia symptoms for women, men, and all respondents are shown in Table 2. Within all groups, subjects reporting a fibromyalgia diagnosis had more pain, less energy, worse sleep, and more/severe depressive symptoms. Moreover, those with a fibromyalgia diagnosis were more likely to report having or once having been diagnosed with depression and irritable bowel syndrome. These relationships all were statistically significant (p < 0.0001).
Table 2
Table 2
Pain, Energy, Sleep, and Depression by Fibromyalgia Diagnosis
Trauma and major life stressors for women, men, and all respondents are shown in Table 3. In general, those respondents reporting a fibromyalgia diagnosis had experienced more trauma and major life stress in their lives. Among women, the differences between the fibromyalgia and no fibromyalgia subgroups across all trauma and major life stressor types were statistically significant. For all subjects, the differences between the fibromyalgia and no fibromyalgia subgroups were statistically significant for all but one trauma type, life-threatening. Among men, the differences between the fibromyalgia and no fibromyalgia subgroups were not significant. Given the small numbers of men and the low fibromyalgia base rate among men, the conclusions that we may draw about men are tentative, at best.
3.3. Multivariable logistic regression
We ran two sets of models, one for all subjects and one for women only. We used logistic regression to examine the linearity assumption between age and fibromyalgia diagnosis. The resulting plot revealed an inverse U-shaped relationship on the logit scale; thus, a quadratic term for age was added to the model. We tested models with education and income (significant in the bivariate analysis), but only education bore a statistically significant relationship to fibromyalgia diagnosis. We, thus, used education as our socioeconomic status proxy.
For both all subjects and women only, the models’ estimates fit the data well (Hosmer and Lemshow goodness-of-fit test p-values > 0.05). The quadratic term for age was significant in both the all subjects and women only models. Figure 1 shows the estimated odds ratios (OR) for fibromyalgia diagnosis at various ages for all subjects. The reference age is 61 (the overall sample mean age), and the odds of having a fibromyalgia diagnosis were highest at approximately age 63. The women-only ORs at various ages were almost identical to the all subjects ORs.
Figure 1
Figure 1
Estimated Odds Ratios for Age and a Fibromyalgia Diagnosis, All Subjects
ORs for the other variables in the two models are shown in Table 4. The references for gender, race/ethnicity, and education were, respectively, female, White (non-White subjects were grouped for these analyses), and some college or less. In the all subjects model (n = 9,644; complete information was available for 9,644 of the 10,988 subjects, 87.8%), male and non-White subjects were less likely to report a fibromyalgia diagnosis (respective ORs = 0.26 and 0.42) as were those with master’s/doctoral degrees (OR = 0.60). Sexual assault/abuse and physical assault/abuse, on the other hand, were associated with an increased likelihood of reporting a fibromyalgia diagnosis (ORs = 1.41 and 1.38, respectively); education-bachelor’s degree or less, life-threatening trauma, emotional abuse/neglect, and major life stressors were not significant. In the women only model (n = 6,463 of 7,259 had complete data available, 89.0%), the results were similar (the ORs were roughly comparable in both models). The highest ORs in both the all-subjects and women-only models were those for sexual abuse/assault and physical abuse/assault (ranging across models from 1.34 to 1.42).
Table 4
Table 4
Multivariable Logistic Regression: Odds Ratios for Fibromyalgia Diagnosis, Yes-No
There were no material differences between the two models summarized above and the corresponding two with imputed data. In the models with income (rather than education), however, the highest income category was significant (OR = 0.69), whereas it was not significant in the available data models.
3.4. Risk differences
Risk differences are shown in Table 5 for all subjects and for women only. For all subjects, there were approximately 0.7 percentage point increases in risk with sexual assault/abuse and physical assault/abuse, and for women, approximately 1 percentage point increases (again, with sexual assault/abuse and physical assault/abuse).
Table 5
Table 5
Multivariate Risk Differences
Among all respondents and women only, two types of traumatic experiences—sexual assault/abuse and physical assault/abuse—were associated with a fibromyalgia diagnosis, whereas life-threatening trauma, emotional abuse/neglect, and major life stress were not. The highest odds ratios in both models were those for sexual and physical assault/abuse. Traumatic stress bore the stronger relationship to fibromyalgia compared to major life stress (as operationalized in the present study), and among the traumatic stressors, the two personal/physical contact types (sexual and physical) had stronger relationships to fibromyalgia. Our data are consistent with studies showing that the consequences of trauma may be expressed as chronic musculoskeletal pain, fatigue as well as sleep and mood disturbances, all cardinal features of fibromyalgia (Crofford, 2007; Bradley, 2008; Schweinhardt et al., 2008; Wolfe and Rasker, 2008). It is important to note, however, that although the trauma versus major life stress distinction we have made is defensible, and to some extent, conventional, there is not universal agreement on the appropriateness of this distinction (Shalev, 1996).
A physician-given fibromyalgia diagnosis was reported by 3.7% of the sample, 4.8% of the women and 1.3% of men. The figures for White individuals, which are more comparable to the widely-cited prevalence estimates (Wolfe et al., 1995) were 4.4% total, 6.2% women, and 1.5% men, all higher than the Wolfe and colleagues’ (1995), 2.0% total, 3.4% women, and 0.5% men. The figures reported herein likely are higher for two reasons: (a) they reflect fibromyalgia in one’s lifetime, not point-in-time and (b) our sample was older (slightly more than three-quarters of our subjects were 50 years and older versus approximately half of Wolfe and colleagues’ normative sample). Also, relatively high percentages of our sample had experienced personal trauma in their lifetime (Table 3) (which, in turn, was associated with fibromyalgia), but we do not have comparative trauma/stress data for the normative sample.
The bulk of the research on fibromyalgia has evaluated women only. In the present study, with the exception of percentages reporting fibromyalgia, the differences between women and men were unremarkable with respect to fibromyalgia symptoms and comorbidities (Table 2). Regarding trauma/major life stressors (Table 3), men had experienced more life-threatening trauma, whereas women had experienced more sexual assault/abuse. Among men, however, differences in traumatic and major life stress between those in the fibromyalgia versus no fibromyalgia subgroups were not statistically significant. Given the small number of men with fibromyalgia (43 in the total sample), however, we have only modest confidence in the stability/interpretability of these patterns.
Race/ethnicity generally is not listed as a risk factor for fibromyalgia (Chakrabarty and Zoorob, 2007). In the present study, however, fibromyalgia rates were considerably lower among non-White respondents. Non-White subjects were on average younger (57.9 versus 63.8 years); specifically, 30.3% of the non-Whites compared to 18.5% of the Whites were under age 50. With respect to education, individuals with master’s or doctoral degrees were much less likely to report fibromyalgia than were those with less education.
In the present sample, the odds of self-reporting a fibromyalgia diagnosis increased until approximately age 63 and declined thereafter, whereas Wolfe and colleagues (1995) reported rate increases through age 79 as did Branco and colleagues (2009). In the latter study, however, with data from France, Portugal, Spain, Germany, and Italy, the authors also reported a curvilinear relationship between age and fibromyalgia. This curvilinear relationship appears quite consistently across studies, although the age that the decrease begins differs. In two studies, for example, the decrease occurred in the 70s (Wolfe et al., 1995; Branco et al., 2009), whereas in four studies, the decrease in fibromyalgia reports occurred in the 60s, just after midlife, which is similar to our data (Makela and Heliovaara, 1991; White et al., 1999; Carmona et al., 2001; Senna et al., 2004). Although the reason for the drop off in fibromyalgia reports with age is unclear (may be decreased incidences or inadequate diagnoses), the curvilinear relationship shown here is consistent with other samples.
4.1 Study limits
Chief among our study limits are fibromyalgia diagnosis, trauma and major life stressor self-reports. Although subjects were asked whether a physician had given them a fibromyalgia diagnosis (life-to-date), we have no data on how these diagnoses were made. Moreover, this is an older sample, and the modern term, fibromyalgia, was not introduced until the mid-1970s, and it was not until the 1980s and 1990s that physicians evaluated fibromyalgia patients more consistently. As such, we cannot be certain that our figures are accurate, and if not, whether in fact they are low. Our data provide, at least, moderate support for the validity of this diagnosis, as the rates that we report are reasonable, given (a) sample age and composition, (b) the rate for women was higher than that of men, and (c) individuals reporting a fibromyalgia diagnosis had more pain, less energy, worse sleep, more/severe depressive symptoms, and life-to-date diagnoses of depression and irritable bowel syndrome.
Also, the trauma/stressor variables all are self-report; none of these experiences were corroborated. Moreover there is the potential for systematic reporting bias; specifically we do not know whether fibromyalgia patients under-report (because they are attending to physical illness causes) or over-report (because they are seeking an illness cause) physical and sexual abuse. The self report bias, however, likely creates an underreporting of a socially unacceptable experience, such as child abuse or violence exposure (Ruiz-Perez et al., 2009), which may have weakened our associations.
Moreover, we were not able to make a distinction between acute versus chronic stress. Acute versus chronic stress can be a particularly important distinction to make, and it is especially important in studies of the consequences of sexual and physical abuse (Herman, 1992; Ruiz-Perez, et al., 2009). Other potentially useful distinctions that we were unable to make were early versus late-life trauma/stress and individual perceptions, such as the degrees of predictability and control for given experiences or the extent to which stressful/traumatic experiences had affected individuals’ lives. We also had no data on whom, if anyone had been diagnosed with PTSD following a traumatic experience.
Finally, our sample is unique. Almost all (99%), for example, were members of the Seventh-day Adventist Church and Blacks were oversampled. How sample uniqueness may have affected our results is not obvious; nevertheless, one must be cautious about generalizing to other groups.
4.2. Conclusion
Despite these limits, it seems reasonable to conclude that trauma—particularly physical and sexual assault/abuse—are associated with self-reporting a physician-given fibromyalgia diagnosis. We recommend that researchers continue to invest in trauma/stress-fibromyalgia research. This work, coupled with genetic and biomarker studies (Bradley, 2008; Dadabhoy et al., 2008), could lead to a better understanding of fibromyalgia, and importantly, more effective treatment (Abeles et al., 2008). We recommend, too, that researchers study trauma and stress and fibromyalgia in men and racial/ethnic minority groups.
Acknowledgments
Funding for this study was from the National Institute on Aging (Biopsychosocial Religion and Health Study, 5R01AG026348-05) and from the National Cancer Institute for the parent study (Adventist Health Study 2, 5R01 CA094594). The authors thank Drs. Peter Przekop, Jerry Lee, and Denise Bellinger for their helpful comments throughout the course of this study.
Footnotes
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
  • Abeles M, Solitar BM, Pillinger MH, Abeles AM. Update on fibromyalgia therapy. The American Journal of Medicine. 2008;121:555–561. [PubMed]
  • American Psychiatric Association. DSM-IV-TR. Washington, DC: American Psychiatric Association; 2000.
  • Bohr T. Problems with myofascial pain syndrome and fibromyalgia syndrome. Neurology. 1996;46:593–597. [PubMed]
  • Boisset-Pioro MH, Esdaile JM, Fitzcharles MA. Sexual and physical abuse in women with fibromyalgia syndrome. Arthritis and Rheumatism. 1995;38:235–241. [PubMed]
  • Bradley LA. Pathophysiologic mechanism of fibromyalgia and its related disorders. Journal of Clinical Psychiatry. 2008;69(2, Supplement):6–13. [PubMed]
  • Branco JC, Bannwarth B, Failde I, Carbonell JA, Blotman F, Spaeth M, Saraiva F, Nacci F, Thomas E, Caubere JP, Lay KL, Taieb C, Matucci-Cerinic M. Prevalence of fibromyalgia: A survey in five European countries. Seminars in Arthritis and Rheumatism. 2009 in press. [PubMed]
  • Butler TL, Fraser GE, Beeson WL, Knutsen SF, Herring RP, Chan J, Sabate J, Montgomery S, Haddad E, Preston-Martin S, Bennett H, Jaceldo-Siegl K. Cohort Profile: The Adventist Health Study-2 (AHS-2) International Journal of Epidemiology. 2008;37:260–265. [PubMed]
  • Carmona L, Ballina J, Gabriel R, Laffon A. On behalf of the EPISER study group. The burden of musculoskeletal diseases in the general population of Spain: Results from a national survey. Annals of Rheumatoid Diseases. 2001;60:1040–1045. [PMC free article] [PubMed]
  • Chakrabarty S, Zoorob R. Fibromyalgia. American Family Physician. 2007;76:247–254. [PubMed]
  • Ciccone DS, Elliott DK, Chandler HK, Nayak S, Raphael KG. Sexual and physical abuse in women with fibromyalgia syndrome: A test of the trauma hypothesis. Clinical Journal of Pain. 2005;21:378–386. [PubMed]
  • Clauw DJ, Taylor-Moon D. Fibromyalgia. American College of Rheumatology. 2006. Retrieved November 11, 2008, from http://www.rheumatology.org/public/factsheets/diseases_and_conditions/fibromyalgia.asp?aud=pat.
  • Crofford LJ. Trauma, stress, and somatic syndromes. Trauma, Violence, & Abuse. 2007;8:299–313. [PubMed]
  • Cusack KJ, Frueh BC, Brady KT. Trauma history screening in a community mental health center. Psychiatric Services. 2004;55:157–162. [PubMed]
  • Dadabhoy D, Crofford LJ, Spaeth M, Russell J, Clauw DJ. Evidence-based biomarkers for fibromyalgia syndrome. Arthritis Research & Therapy 10:211, article 10.1186/ar2443. 2008. Retrieved from http://arthritis-research.com/content/10/4/211. [PMC free article] [PubMed]
  • Goldenberg DL. Fibromyalgia syndrome. An emerging but controversial condition. Journal of the American Medical Association. 1987;257:2782–2787. [PubMed]
  • Herman JL. Trauma and recovery. New York: Basic Books; 1992.
  • Inanici F, Yunus MB. History of fibromyalgia: Past and present. Current Pain and Headache Reports. 2004;8:369–378. [PubMed]
  • Kohout FJ, Berkman LF, Evans DA, Cornoni-Huntley J. Two shorter forms of the CES-D depression symptoms index. Journal of Aging and Health. 1993;5:179–193. [PubMed]
  • Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, Jordan JM, Katz JN, Kremers HM, Wolfe F. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis & Rheumatism. 2008;58:26–35. [PMC free article] [PubMed]
  • Lazarus RS, Folkman S. Stress, appraisal, and coping. New York: Springer; 1984.
  • Lee JW, Morton KR, Walters J, Bellinger DL, Butler TL, Wilson C, Walsh E, Ellison CG, McKenzie MM, Fraser GE. Cohort Profile: The Biopsychosocial Religion and Health Study (BRHS) International Journal of Epidemiology. 2008. PMID 19052114 http://ije.oxfordjournals.org/cgi/citmgr?gca=intjepid;dyn244v1. [PMC free article] [PubMed]
  • Makela JO, Heliovaara M. Prevalence of primary fibromyalgia in the Finnish population. British Medical Journal. 1991;303:216–219. [PMC free article] [PubMed]
  • McHugo GJ, Caspi Y, Kammerer N, Mazelis R, Jackson EW, Russell L, Clark C, Liebschutz J, Kimerling R. The assessment of trauma history in women with co-occurring substance abuse and mental disorders and a history of interpersonal violence. Journal of Behavioral Health Services & Research. 2005;32:113–127. [PubMed]
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases. What is fibromyalgia? 2007. Retrieved November 11, 2008 from http://www.niams.nih.gov/Health_Info/Fibromyalgia/fibromyalgia_ff.asp.
  • Ohayon MM. Epidemiology of insomnia: What we know and what we still need to learn. Sleep Medical Review. 2002;6:97–111. [PubMed]
  • Raphael KG, Chandler HK, Ciccone DS. Is childhood abuse a risk factor for chronic pain in adulthood? Current Pain and Headache Reports. 2004;8:99–110. [PubMed]
  • Romans S, Cohen M. Unexplained and underpowered: The relationship between psychosomatic disorders and interpersonal abuse – A critical review. Harvard Review of Psychiatry. 2008;16:35–54. [PubMed]
  • Ruiz-Perez I, Plazaola-Castano J, Caliz-Caliz R, Rodriguez-Calvo I, Garcia-Sanchez A, Ferrer-Gonzalez MA, Guzman-Ubeda M, del Rio-Lozano M, Garcia ILC. Risk factors for fibromyalgia: The role of violence against women. Clinical Rheumatology. 2009;28:777–786. [PubMed]
  • Russell IJ, Raphael KG. Fibromyalgia syndrome: Presentation, diagnosis, differential diagnosis, and vulnerability. CNS Spectrums. 2008;13(3 Supplement 5):6–11. [PubMed]
  • Ryff CD, Singer BH, Palmersheim KA. Social inequalities in health and well-being: The role of relational and religious protective factors. In: Brim OG, Ryff CD, Kessler RC, editors. How healthy are we?: A national study of well-being at midlife. Chicago: University of Chicago Press; 2004. pp. 90–123.
  • Schweinhardt P, Sauro KM, Bushnell MC. Fibromyalgia: A disorder of the brain? Neuroscientist. 2008;14:415–421. [PubMed]
  • Shalev AY. Stress versus traumatic stress: From acute homeostatic reactions to chronic psychopathology. In: van der Kolk BA, McFarlane AC, Weisaeth L, editors. Traumatic stress: The effects of overwhelming experience on mind, body, and society. New York: Guilford; 1996. pp. 77–101.
  • Senna ER, DeBarros ALP, Silva EO, Costa IF, Pereira LV, Ciconelli RM, Ferraz MB. Prevalence of rheumatic diseases in Brazil: A study using the COPCORD approach. Journal of Rheumatology. 2004;31:594–597. [PubMed]
  • Starlanyl D, Copeland ME. Fibromyalgia and chronic myofascial pain: A survival manual. Oakland, CA: New Harbinger Publications; 2001.
  • Van Houdenhove B, Neerinckx E, Lysens R, Vertommen H, Can Houdenhove L, Onghena P, Westhovens R, D’Hooghe MB. Victimization in chronic fatigue syndrome and fibromyalgia in tertiary care: A controlled study on prevalence and characteristics. Psychosomatics. 2001;42:21–28. [PubMed]
  • Walker EA, Keegan D, Gardner G, Sullivan M, Bernstein D, Katon WJ. Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: II. Sexual, physical, and emotional abuse and neglect. Psychosomatic Medicine. 1997;59:572–577. [PubMed]
  • Ware JE, Jr, Kosinski M, Dewey JE. How to score version 2 of the SF-12® health survey. Lincoln, RI: QualityMetric, Inc.; 2002.
  • White KP, Speechley M, Harth M, Ostbye T. The London fibromyalgia epidemiology study: The prevalence of fibromyalgia syndrome in London, Ontario. Journal of Rheumatology. 1999;26:1570–1576. [PubMed]
  • Wolfe F. Fibromyalgia wars. The Journal of Rheumatology. 2009;36:671–678. [PubMed]
  • Wolfe F, Rasker JJ. Fibromyalgia. In: Firestein GS, Budd RC, Harris EE Jr, McInnes IB, Ruddy S, Sergent JS, editors. Kelley’s Textbook of Rheumatology. 8th ed. Amsterdam: Elsevier; 2008.
  • Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis and Rheumatism. 1995;38:19–28. [PubMed]
  • Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis and Rheumatism. 1990;33:160–172. [PubMed]
  • Yunus M, Masi AT, Calabro JJ, Miller KA, Feigenbaum SL. Primary fibromyalgia (fibrositis): Clinical study of 50 patients with matched normal controls. Seminars in Arthritis and Rheumatism. 1981;11:151–171. [PubMed]